| Literature DB >> 30997933 |
Yutaro Yamagata1,2, Yukiko Muramoto1, Sho Miyamoto1,3, Keiko Shindo1, Masahiro Nakano1,2, Takeshi Noda1,2.
Abstract
Defective interfering (DI) influenza viruses carry a large deletion in a gene segment that interferes with the replication of infectious virus; thus, such viruses have potential for antiviral therapy. However, because DI viruses cannot replicate autonomously without the aid of an infectious helper virus, clonal DI virus stocks that are not contaminated with helper virus have not yet been generated. To overcome this problem, we used reverse genetics to generate a clonal DI virus with a PB2 DI gene, amplified the clonal DI virus using a cell line stably expressing the PB2 protein, and confirmed its ability to interfere with infectious virus replication in vitro. Thus, our approach is suitable for obtaining purely clonal DI viruses, will contribute to the understanding of DI virus interference mechanisms and can be used to develop DI virus-based antivirals.Entities:
Keywords: clonal defective interfering virus; influenza virus
Mesh:
Substances:
Year: 2019 PMID: 30997933 DOI: 10.1111/1348-0421.12681
Source DB: PubMed Journal: Microbiol Immunol ISSN: 0385-5600 Impact factor: 1.955